Key Statistics for PROB
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (SEK) (ttm)
|Est. EPS (SEK) (12/2013)
|Est. PEG Ratio
|Market Cap (M SEK)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (SEK)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PROB
- Net Income (M/SEK)
Probi AB carries out research and development in probiotics. The Company has three main research areas: surgery and medicine, foodstuff technology, and microbiology. Probi has developed the fruit drink ProViva, containing active bioculture intended to counteract harmful bacteria and strengthen the immune system. The Company also develops animal feed. Probi markets internationally.
More Company Profile & Key Executives for PROB
|Per LundinChairman||Michael S OredssonChief Executive Officer|
|Niklas BrandtChief Financial Officer||Niklas BjaerumVP:Marketing & Sales|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries